Effect of bromocryptine on 20α-hydroxysteroiddehydrogenase regulation in the corpus luteum of the pregnant rat
Abstract. Pregnant Sprague Dawley rats were passively immunized with antiserum to bovine luteinizing hormone (anti-LH) on day 10 of pregnancy, and treated with 1 mg/day or 1.5 mg/day of the prolactin (Prl) inhibitor bromocryptine (BEC) between days 10 to 12 or 9 to 12, respectively. On day 12 a laparotomy was performed to assess the state of pregnancy and to remove the ovaries for histochemical detection of 20α-hydroxysteroiddehydrogenase (20α-OHSD) in the corpora lutea of pregnancy. In a second experiment pregnant rats were treated with 1.5mg BEC/day from days 17 to 22, checked for foetal state and ovariectomized on day 22 before giving birth. Treatment with BEC in effective doses did not interfere with anti-LH-induced termination of pregnancy and consequent reappearance of 20α-OHSD activity on day 12, or with spontanenous recurrence of enzyme activity at the end of gestation. It is concluded that Prl has no direct and immediate role in 20α-OHSD regulation, at least on day 12, although substitution by endogenous rat placental lactogen at the end of pregnancy cannot be excluded.